MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways.
(Q39095883)
scientific article published on 16 September 2013
scientific article published on 16 September 2013
Language:
Current Data About
MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways.